LZTR1 and sarcoma: Though the mechanism has yet to be elucidated in sarcomas, mutations or deletions of LZTR1 disrupt RAS regulations by LZTR1-mediated ubiquitination and allow glioblastoma to retain its proliferative features (16, 17).